Bilieye
Non-invasive Remotely Solution for Monitoring Jaundice in Newborns
Startup Pre-Seed Health Tech & Life Sciences Est. 2024
Total Raised
$700K
Pre-Seed
Last Round
$700K
1 rounds
Team
1
1-10 employees
Confidence
80/100
Patents
1
About
Bilieye is redefining neonatal care with a revolutionary, non-invasive app that allows parents and healthcare providers to monitor a baby’s bilirubin levels remotely using just a photo of the baby’s eyes. Bilirubin, a substance in the blood, can indicate liver dysfunction or conditions like jaundice when present in high levels. Jaundice is common in newborns, affecting 60-80% of babies during their first week of life. Currently, bilirubin levels are monitored through invasive blood tests that often require painful heel pricks, repeated hospital visits, and added stress for families. Bilieye cutting-edge technology provides a simple, stress-free alternative, allowing parents to take a quick photo of their baby’s eyes with their smartphone to monitor bilirubin levels accurately and safely. Its software is designed to work for babies of all skin tones, ensuring that every family has access to this essential health monitoring tool. The company's mission is to enhance the healthcare experience for families by providing a safe, effective, and accessible alternative to traditional bilirubin monitoring.
Classification
Sector
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Core Technology
Platforms & InterfacesSoftware
Target Customer
ConsumersDemographics & FamilyBabiesHealthcare & Life SciencesHealthcarePatients
Business Model
B2B2C
Tags
babiesdigital-healthcarediagnostics
Funding & Events
Mar 2025
Pre-Seed $700K
Details
Product Stage
Clinical Trial
Employees
1-10
Exact Count
3
District
North District
Founded
2024
Registrar
517105755
Locations
Haifa, Israel
Links
Website
LinkedIn
Admin
Last Update
Mar 20, 2025
Verified by
Yanina Wainscheinker
Claimed
Yes
Missing
sector, video or image, news, markets, not claimed
Team (1)
Chen Binyamin
Co-founder
Founder
Internal
Created by
Chen Binyamin (chen.b@bilieye.com)
Created
2025-02-20T00:00:00.000Z